VASH2 Promotes Cell Proliferation and Resistance to Doxorubicin in Non-Small Cell Lung Cancer via AKT Signaling

Vasohibin2 (VASH2), a proangiogenic factor, has been demonstrated to play an oncogenic role in some common human cancers. However, the detailed function of VASH2 in non-small cell lung cancer (NSCLC) has not previously been studied. In this study, we found that VASH2 was significantly upregulated in...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Xiangbin, Liao, Zefei, Zou, Shuangyou, Ma, Liangyun, Wang, Aimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cognizant Communication Corporation 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851523/
https://www.ncbi.nlm.nih.gov/pubmed/30940294
http://dx.doi.org/10.3727/096504019X15509383469698

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851523/
https://www.ncbi.nlm.nih.gov/pubmed/30940294
http://dx.doi.org/10.3727/096504019X15509383469698

Ejemplares similares